GLP-1 drugs: what Michigan Medicaid paid

Q: Does a paid prescription mean Michigan Medicaid covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Q: Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

Q: What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.

Michigan Medicaid shows a published payment figure for 8 of the 8 GLP-1 products this site tracks, in the latest federal quarter. This site has not yet read Michigan Medicaid's own coverage rule, so the figures below are a payment history and nothing here tells you what the program will decide next.

By the Covered Weight editorial team · Updated Aug 8, 2026. Research and sourcing by Evan Reid.

What Michigan Medicaid’s payment record shows

In 2026Q1, the product Michigan Medicaid paid for most often was Zepbound®, at 44,662 prescriptions¹ of the 122,998 to 123,241^{1,7,13,19,25,31,37,43} across all 8 products, or 36 percent of the published count.

Michigan Medicaid itself reimbursed at least $136,070,463 for these products in the quarter, about $1,107 per prescription. Pharmacies were paid $138,397,124 in total, the difference being what other payers covered on the same claims. The costliest per prescription was Wegovy®, at about $1,263.

Every dollar figure on this page is what pharmacies were paid, before rebates. Manufacturers pay Medicaid programs rebates on these products, the federal file states that its amounts are not reduced by them, and CMS publishes no rebate figure per drug. So what Michigan Medicaid finally kept is lower than what is shown here, by an amount this site cannot source.

Paid prescriptions per quarter, Michigan Medicaid. The line is what the federal file published and the axis starts at zero. The shaded band is what the file leaves possible above it: each withheld product code stands for between one and ten prescriptions, so a wide band means a heavily suppressed record rather than a busy one. A gap in the line is a quarter the file did not report, never a zero.

What Michigan Medicaid paid, product by product

For what each product is approved to treat, the split that decides most coverage questions, compare the products themselves.

Route, prescriptions, what Michigan Medicaid paid and what all payers paid, for each GLP-1 product, 2026Q1
Product	Paid through	Prescriptions	Shareof this program	Program paidbefore rebates	All payers	Program per Rx
tirzepatideZepbound®	Both40,869 managed care, 3,793 direct	at least 44,662¹	36%	$45,855,495	$46,247,075	$1,027
tirzepatideMounjaro®	Both18,363 managed care, 1,588 direct	at least 19,951⁷	16%	$22,095,371	$22,960,727	$1,107
semaglutideWegovy®	Both29,197 managed care, 2,768 direct	at least 31,965¹³	26%	$40,378,996	$40,974,214	$1,263
semaglutideOzempic®	Both23,828 managed care, 1,508 direct	at least 25,336¹⁹	21%	$26,717,230	$27,168,890	$1,055
semaglutideRybelsus®	Both521 managed care, 40 direct	at least 561²⁵	<1%	$681,348	$704,196	$1,215
liraglutideSaxenda®	Both83 managed care, 15 direct	98³¹	<1%	$102,099	$102,099	$1,042
liraglutideVictoza®	Both167 managed care, 18 direct	at least 185³⁷	<1%	$131,722	$131,722	$712
liraglutideliraglutide (generic)	Managed care	at least 213⁴³	<1%	$108,201	$108,201	$508

Michigan Medicaid publishes claims on both routes: paid directly by the program, and paid through the managed-care plans it contracts with. The figures above combine the two, so which one your own card names decides who answers a question about your prescription.

Against enrollment, that is 60.0 to 60.1 prescriptions per thousand people enrolled in Michigan Medicaid, on an average of 2,050,294 enrollees across the quarter. A raw count compares programs by how many people they cover; this is the figure that compares them by what they paid for.

2026Q1 covers January through March 2026, and it is the newest quarter CMS has published; that file was released on July 10, 2026. Every count here is a prescription filled rather than a person: one patient on a monthly product contributes several in a quarter, so nothing on this page says how many people take these products.

The file withheld 7 of the 168 product-quarters it holds a row for here, which is 4 percent. Each withheld cell records prescriptions that were paid for and a count that is not disclosed, so any total on this page that includes one is a floor rather than a sum.

Ozempic®, Rybelsus® and Victoza® carry a published count in every one of the 21 quarters, which is the closest this record comes to showing a product paid for routinely.

21 quarters, 2021Q1 to 2026Q1

One quarter cannot tell you whether Michigan Medicaid pays for a product routinely or barely at all, and a single withheld cell reads as an absence when it is not.

Show what Michigan Medicaid paid for each product, quarter by quarter

Prescriptions Michigan Medicaid paid for, by product and quarter, 2021Q1 to 2026Q1
Product	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1
tirzepatideZepbound®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴No row	at least 44 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld⁴At least$45,846 paid	at least 671 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld³At least$694,727 paid	at least 2,866 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld³At least$2,869,811 paid	at least 8,652 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld³At least$8,601,104 paid	at least 15,115 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld³At least$14,795,933 paid	at least 22,943 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²At least$23,470,068 paid	at least 35,656 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²At least$36,712,760 paid	at least 46,946 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²At least$48,576,599 paid	at least 56,384 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²At least$58,158,044 paid	at least 44,662 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹At least$45,855,495 paid
tirzepatideMounjaro®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter¹¹No row	withheld as a small cell paid prescriptions in the quarter (2022Q2)every reporting cell was withheld, so nothing is observable¹¹Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q3)every reporting cell was withheld, so nothing is observable¹¹Withheld4 of 4 product codes withheld	at least 32 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld¹¹At least$27,342 paid	at least 603 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld¹⁰At least$490,327 paid	at least 2,382 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld¹⁰At least$2,002,570 paid	at least 4,050 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld¹⁰At least$3,465,819 paid	at least 5,787 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld¹⁰At least$5,323,084 paid	at least 7,635 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld⁹At least$7,322,474 paid	at least 8,852 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld⁹At least$8,702,382 paid	at least 10,612 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld⁹At least$10,601,657 paid	at least 12,271 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld⁹At least$12,264,761 paid	at least 13,654 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld⁸At least$14,034,874 paid	at least 15,940 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld⁸At least$16,603,471 paid	at least 17,616 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld⁸At least$18,581,811 paid	at least 19,322 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld⁸At least$20,603,399 paid	at least 19,951 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld⁷At least$22,095,371 paid
semaglutideWegovy®range 1,211 to 49,798	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹⁸No row	withheld as a small cell paid prescriptions in the quarter (2021Q3)every reporting cell was withheld, so nothing is observable¹⁸Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2021Q4)every reporting cell was withheld, so nothing is observable¹⁸Withheld5 of 5 product codes withheld	at least 627 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld¹⁷At least$770,053 paid	1,211 paid prescriptions in the quarter (2022Q2)¹⁷Count$1,422,847 paid	at least 936 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld¹⁷At least$1,117,121 paid	at least 1,246 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld¹⁷At least$1,539,639 paid	10,560 paid prescriptions in the quarter (2023Q1)¹⁶Count$13,212,477 paid	22,033 paid prescriptions in the quarter (2023Q2)¹⁶Count$27,447,084 paid	19,198 paid prescriptions in the quarter (2023Q3)¹⁶Count$24,017,102 paid	16,659 paid prescriptions in the quarter (2023Q4)¹⁶Count$21,082,934 paid	19,407 paid prescriptions in the quarter (2024Q1)¹⁵Count$24,601,210 paid	34,683 paid prescriptions in the quarter (2024Q2)¹⁵Count$44,081,222 paid	43,746 paid prescriptions in the quarter (2024Q3)¹⁵Count$55,592,617 paid	44,572 paid prescriptions in the quarter (2024Q4)¹⁵Count$55,608,563 paid	47,209 paid prescriptions in the quarter (2025Q1)¹⁴Count$60,265,803 paid	49,798 paid prescriptions in the quarter (2025Q2)¹⁴Count$63,874,754 paid	49,629 paid prescriptions in the quarter (2025Q3)¹⁴Count$63,748,408 paid	48,205 paid prescriptions in the quarter (2025Q4)¹⁴Count$61,710,538 paid	at least 31,965 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹³At least$40,378,996 paid
semaglutideOzempic®range 2,855 to 3,000	2,855 paid prescriptions in the quarter (2021Q1)²⁴Count$2,378,839 paid	3,000 paid prescriptions in the quarter (2021Q2)²⁴Count$2,530,870 paid	at least 3,145 paid prescriptions in the quarter (2021Q3)a floor, because some reporting cells were withheld²⁴At least$2,646,100 paid	at least 3,298 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld²⁴At least$2,784,246 paid	at least 3,590 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld²³At least$3,297,611 paid	at least 4,033 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²³At least$3,654,667 paid	at least 4,328 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²³At least$3,815,918 paid	at least 4,649 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²³At least$4,038,884 paid	at least 6,326 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²²At least$5,751,883 paid	at least 7,415 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld²²At least$6,736,100 paid	at least 7,952 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld²²At least$7,205,908 paid	at least 7,540 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld²²At least$6,958,859 paid	at least 8,341 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld²¹At least$7,972,450 paid	at least 10,367 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld²¹At least$10,024,665 paid	at least 11,110 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld²¹At least$10,832,956 paid	at least 12,852 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld²¹At least$12,281,819 paid	at least 17,578 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²⁰At least$17,485,224 paid	at least 21,506 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²⁰At least$21,532,806 paid	at least 23,555 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²⁰At least$23,837,883 paid	at least 24,368 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²⁰At least$24,903,086 paid	at least 25,336 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹⁹At least$26,717,230 paid
semaglutideRybelsus®range 228 to 627	at least 85 paid prescriptions in the quarter (2021Q1)a floor, because some reporting cells were withheld³⁰At least$59,211 paid	at least 167 paid prescriptions in the quarter (2021Q2)a floor, because some reporting cells were withheld³⁰At least$114,897 paid	228 paid prescriptions in the quarter (2021Q3)³⁰Count$175,639 paid	at least 228 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld³⁰At least$198,580 paid	at least 265 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld²⁹At least$255,517 paid	at least 382 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²⁹At least$342,036 paid	at least 429 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²⁹At least$402,793 paid	at least 441 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²⁹At least$452,067 paid	at least 627 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²⁸At least$651,124 paid	at least 634 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld²⁸At least$656,380 paid	at least 630 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld²⁸At least$639,196 paid	at least 635 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld²⁸At least$659,585 paid	at least 675 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld²⁷At least$726,361 paid	at least 845 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld²⁷At least$961,628 paid	at least 718 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld²⁷At least$845,760 paid	at least 649 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld²⁷At least$764,469 paid	627 paid prescriptions in the quarter (2025Q1)²⁶Count$750,537 paid	at least 573 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²⁶At least$693,378 paid	578 paid prescriptions in the quarter (2025Q3)²⁶Count$694,971 paid	at least 514 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²⁶At least$606,839 paid	at least 561 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld²⁵At least$681,348 paid
liraglutideSaxenda®range 25 to 9,125, down 201 on the quarter before	withheld as a small cell paid prescriptions in the quarter (2021Q1)every reporting cell was withheld, so nothing is observable³⁶Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2021Q2)every reporting cell was withheld, so nothing is observable³⁶Withheld2 of 2 product codes withheld	25 paid prescriptions in the quarter (2021Q3)³⁶Count$14,678 paid	at least 17 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld³⁶At least$17,378 paid	578 paid prescriptions in the quarter (2022Q1)³⁵Count$673,961 paid	3,202 paid prescriptions in the quarter (2022Q2)³⁵Count$3,719,917 paid	6,401 paid prescriptions in the quarter (2022Q3)³⁵Count$7,465,761 paid	8,961 paid prescriptions in the quarter (2022Q4)³⁵Count$10,408,077 paid	9,125 paid prescriptions in the quarter (2023Q1)³⁴Count$10,629,447 paid	8,031 paid prescriptions in the quarter (2023Q2)³⁴Count$9,324,645 paid	5,196 paid prescriptions in the quarter (2023Q3)³⁴Count$5,775,301 paid	2,354 paid prescriptions in the quarter (2023Q4)³⁴Count$2,706,404 paid	760 paid prescriptions in the quarter (2024Q1)³³Count$833,717 paid	1,832 paid prescriptions in the quarter (2024Q2)³³Count$2,097,888 paid	1,706 paid prescriptions in the quarter (2024Q3)³³Count$2,014,500 paid	1,328 paid prescriptions in the quarter (2024Q4)³³Count$1,568,199 paid	958 paid prescriptions in the quarter (2025Q1)³²Count$1,174,034 paid	710 paid prescriptions in the quarter (2025Q2)³²Count$864,346 paid	475 paid prescriptions in the quarter (2025Q3)³²Count$566,892 paid	299 paid prescriptions in the quarter (2025Q4)³²Count$342,219 paid	98 paid prescriptions in the quarter (2026Q1)³¹Count$102,099 paid
liraglutideVictoza®range 555 to 12,550	10,291 paid prescriptions in the quarter (2021Q1)⁴²Count$9,044,732 paid	12,550 paid prescriptions in the quarter (2021Q2)⁴²Count$11,170,060 paid	12,163 paid prescriptions in the quarter (2021Q3)⁴²Count$11,212,128 paid	11,067 paid prescriptions in the quarter (2021Q4)⁴²Count$10,566,941 paid	10,442 paid prescriptions in the quarter (2022Q1)⁴¹Count$10,598,877 paid	9,826 paid prescriptions in the quarter (2022Q2)⁴¹Count$10,235,890 paid	8,958 paid prescriptions in the quarter (2022Q3)⁴¹Count$9,442,161 paid	8,421 paid prescriptions in the quarter (2022Q4)⁴¹Count$8,836,395 paid	8,304 paid prescriptions in the quarter (2023Q1)⁴⁰Count$9,139,226 paid	7,299 paid prescriptions in the quarter (2023Q2)⁴⁰Count$8,133,380 paid	6,214 paid prescriptions in the quarter (2023Q3)⁴⁰Count$6,876,035 paid	5,193 paid prescriptions in the quarter (2023Q4)⁴⁰Count$5,484,236 paid	3,775 paid prescriptions in the quarter (2024Q1)³⁹Count$2,856,357 paid	2,868 paid prescriptions in the quarter (2024Q2)³⁹Count$2,122,132 paid	1,791 paid prescriptions in the quarter (2024Q3)³⁹Count$1,290,954 paid	1,456 paid prescriptions in the quarter (2024Q4)³⁹Count$1,054,311 paid	555 paid prescriptions in the quarter (2025Q1)³⁸Count$355,171 paid	at least 189 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld³⁸At least$119,222 paid	at least 169 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld³⁸At least$123,963 paid	at least 160 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld³⁸At least$113,767 paid	at least 185 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld³⁷At least$131,722 paid
liraglutideliraglutide (generic)	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter⁴⁵No row	withheld as a small cell paid prescriptions in the quarter (2024Q2)every reporting cell was withheld, so nothing is observable⁴⁵Withheld2 of 2 product codes withheld	at least 262 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld⁴⁵At least$182,669 paid	at least 218 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld⁴⁵At least$133,203 paid	at least 314 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld⁴⁴At least$179,995 paid	at least 310 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld⁴⁴At least$168,237 paid	at least 295 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld⁴⁴At least$144,039 paid	at least 228 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld⁴⁴At least$112,340 paid	at least 213 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld⁴³At least$108,201 paid

What this page cannot tell you

Whether Michigan Medicaid covers these products is decided by a document this site has not read yet: its preferred drug list and the prior-authorization criteria behind it. Until that is read and quoted, the payment history above is all this page asserts. Start from the notice or the drug list the program sent you, and check which document governs your plan first, because no state rule reaches a self-funded employer plan at all.

Open Michigan in the coverage explorer to see all 21 quarters of trend per product and switch jurisdictions without leaving the table.

Compare another jurisdiction from the national comparison.

Documents this page reads

48 documents, cited by number above. Each opens to its section, its effective date, and the quote the fact came from.

SDUD 2026, Zepbound, MI
State Drug Utilization Data 2026, Datastore query result, product_name like ZEPBOUND%, state MI, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "MI", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "8747"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Zepbound, MI
State Drug Utilization Data 2025, Datastore query result, product_name like ZEPBOUND%, state MI, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MI", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "12001"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Zepbound, MI
State Drug Utilization Data 2024, Datastore query result, product_name like ZEPBOUND%, state MI, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MI", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "3942"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Zepbound, MI
State Drug Utilization Data 2023, Datastore query result, product_name like ZEPBOUND%, state MI, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MI", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "44"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Zepbound, MI
State Drug Utilization Data 2022, Datastore query result, product_name like ZEPBOUND%, state MI, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MI", "product_name": "product_name like ZEPBOUND%, state MI, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Zepbound, MI
State Drug Utilization Data 2021, Datastore query result, product_name like ZEPBOUND%, state MI, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MI", "product_name": "product_name like ZEPBOUND%, state MI, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Mounjaro, MI
State Drug Utilization Data 2026, Datastore query result, product_name like MOUNJARO%, state MI, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "MI", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "3713"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Mounjaro, MI
State Drug Utilization Data 2025, Datastore query result, product_name like MOUNJARO%, state MI, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MI", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "3601"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Mounjaro, MI
State Drug Utilization Data 2024, Datastore query result, product_name like MOUNJARO%, state MI, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MI", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "2696"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Mounjaro, MI
State Drug Utilization Data 2023, Datastore query result, product_name like MOUNJARO%, state MI, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MI", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "1459"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Mounjaro, MI
State Drug Utilization Data 2022, Datastore query result, product_name like MOUNJARO%, state MI, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MI", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "17"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Mounjaro, MI
State Drug Utilization Data 2021, Datastore query result, product_name like MOUNJARO%, state MI, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MI", "product_name": "product_name like MOUNJARO%, state MI, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Wegovy, MI
State Drug Utilization Data 2026, Datastore query result, product_name like WEGOVY%, state MI, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "MI", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "WEGOVY ", "suppression_used": "false", "number_of_prescriptions": "11704"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Wegovy, MI
State Drug Utilization Data 2025, Datastore query result, product_name like WEGOVY%, state MI, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MI", "year": "2025", "quarter": "3", "utilization_type": "MCOU", "product_name": "WEGOVY ", "suppression_used": "false", "number_of_prescriptions": "15335"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Wegovy, MI
State Drug Utilization Data 2024, Datastore query result, product_name like WEGOVY%, state MI, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MI", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY ", "suppression_used": "false", "number_of_prescriptions": "12906"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Wegovy, MI
State Drug Utilization Data 2023, Datastore query result, product_name like WEGOVY%, state MI, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MI", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY ", "suppression_used": "false", "number_of_prescriptions": "8197"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Wegovy, MI
State Drug Utilization Data 2022, Datastore query result, product_name like WEGOVY%, state MI, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MI", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY ", "suppression_used": "false", "number_of_prescriptions": "646"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Wegovy, MI
State Drug Utilization Data 2021, Datastore query result, product_name like WEGOVY%, state MI, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MI", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Ozempic, MI
State Drug Utilization Data 2026, Datastore query result, product_name like OZEMPIC%, state MI, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "MI", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "9193"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Ozempic, MI
State Drug Utilization Data 2025, Datastore query result, product_name like OZEMPIC%, state MI, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MI", "year": "2025", "quarter": "3", "utilization_type": "MCOU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "9080"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Ozempic, MI
State Drug Utilization Data 2024, Datastore query result, product_name like OZEMPIC%, state MI, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MI", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "4481"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Ozempic, MI
State Drug Utilization Data 2023, Datastore query result, product_name like OZEMPIC%, state MI, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MI", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "2597"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Ozempic, MI
State Drug Utilization Data 2022, Datastore query result, product_name like OZEMPIC%, state MI, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MI", "year": "2022", "quarter": "2", "utilization_type": "MCOU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "1840"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Ozempic, MI
State Drug Utilization Data 2021, Datastore query result, product_name like OZEMPIC%, state MI, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MI", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "1685"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Rybelsus, MI
State Drug Utilization Data 2026, Datastore query result, product_name like RYBELSUS%, state MI, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "MI", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "186"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Rybelsus, MI
State Drug Utilization Data 2025, Datastore query result, product_name like RYBELSUS%, state MI, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MI", "year": "2025", "quarter": "1", "utilization_type": "MCOU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "239"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Rybelsus, MI
State Drug Utilization Data 2024, Datastore query result, product_name like RYBELSUS%, state MI, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MI", "year": "2024", "quarter": "2", "utilization_type": "MCOU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "320"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Rybelsus, MI
State Drug Utilization Data 2023, Datastore query result, product_name like RYBELSUS%, state MI, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MI", "year": "2023", "quarter": "2", "utilization_type": "MCOU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "227"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Rybelsus, MI
State Drug Utilization Data 2022, Datastore query result, product_name like RYBELSUS%, state MI, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MI", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "167"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Rybelsus, MI
State Drug Utilization Data 2021, Datastore query result, product_name like RYBELSUS%, state MI, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MI", "year": "2021", "quarter": "3", "utilization_type": "MCOU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "84"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Saxenda, MI
State Drug Utilization Data 2026, Datastore query result, product_name like SAXENDA%, state MI, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "MI", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "83"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Saxenda, MI
State Drug Utilization Data 2025, Datastore query result, product_name like SAXENDA%, state MI, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MI", "year": "2025", "quarter": "1", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "885"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Saxenda, MI
State Drug Utilization Data 2024, Datastore query result, product_name like SAXENDA%, state MI, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MI", "year": "2024", "quarter": "2", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "1697"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Saxenda, MI
State Drug Utilization Data 2023, Datastore query result, product_name like SAXENDA%, state MI, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MI", "year": "2023", "quarter": "1", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "8099"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Saxenda, MI
State Drug Utilization Data 2022, Datastore query result, product_name like SAXENDA%, state MI, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MI", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "8037"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Saxenda, MI
State Drug Utilization Data 2021, Datastore query result, product_name like SAXENDA%, state MI, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MI", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "17"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Victoza, MI
State Drug Utilization Data 2026, Datastore query result, product_name like VICTOZA%, state MI, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "MI", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "100"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Victoza, MI
State Drug Utilization Data 2025, Datastore query result, product_name like VICTOZA%, state MI, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MI", "year": "2025", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 2-", "suppression_used": "false", "number_of_prescriptions": "299"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Victoza, MI
State Drug Utilization Data 2024, Datastore query result, product_name like VICTOZA%, state MI, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MI", "year": "2024", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "2387"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Victoza, MI
State Drug Utilization Data 2023, Datastore query result, product_name like VICTOZA%, state MI, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MI", "year": "2023", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "5149"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Victoza, MI
State Drug Utilization Data 2022, Datastore query result, product_name like VICTOZA%, state MI, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MI", "year": "2022", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "6233"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Victoza, MI
State Drug Utilization Data 2021, Datastore query result, product_name like VICTOZA%, state MI, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MI", "year": "2021", "quarter": "3", "utilization_type": "MCOU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "7119"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Liraglutid, MI
State Drug Utilization Data 2026, Datastore query result, product_name like LIRAGLUTID%, state MI, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "MI", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "69"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Liraglutid, MI
State Drug Utilization Data 2025, Datastore query result, product_name like LIRAGLUTID%, state MI, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MI", "year": "2025", "quarter": "1", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "135"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Liraglutid, MI
State Drug Utilization Data 2024, Datastore query result, product_name like LIRAGLUTID%, state MI, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MI", "year": "2024", "quarter": "3", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "177"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Liraglutid, MI
State Drug Utilization Data 2023, Datastore query result, product_name like LIRAGLUTID%, state MI, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MI", "product_name": "product_name like LIRAGLUTID%, state MI, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Liraglutid, MI
State Drug Utilization Data 2022, Datastore query result, product_name like LIRAGLUTID%, state MI, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MI", "product_name": "product_name like LIRAGLUTID%, state MI, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Liraglutid, MI
State Drug Utilization Data 2021, Datastore query result, product_name like LIRAGLUTID%, state MI, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MI", "product_name": "product_name like LIRAGLUTID%, state MI, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026

How the quoted row is presented, for 42 of these documents

One row of the API response for the query in url, with the fields that do not bear on this fact omitted and the rest left exactly as the API returns them, including the trailing spaces the ten-character product_name field pads with. Open the url to re-read the whole result set and re-sum it.

How the quoted row is presented, for 6 of these documents

The query in url returns an empty result set, which is the evidence. An absence cannot be quoted, so the record states the query and its count instead.

Common questions

Does a paid prescription mean Michigan Medicaid covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.